Elevance Health (ELV) Is Back In The Spotlight, What Is Drawing Attention?
Simply Wall Street
Elevance Health (ELV) has recently drawn attention due to its share price movement, with the stock closing at US$388.82. Despite some softer short-term trading, the company's year-to-date and one-year returns are positive. The most popular narrative suggests ELV is 14% undervalued with a fair value of $451.38, driven by the expected positive impact of AI and digital platforms on cost management and net margins.
Read the full story
This is a short summary. The complete article is published by Simply Wall Street.
Headline and summary aggregated from public news feeds. For information only — not financial advice.